Document is current
Any future updates will be listed below
-
Authors
Metoki, Hirohito
Iwama, Noriyuki
Hamada, Hirotaka
Satoh, Michihiro
Murakami, Takahisa
Ishikuro, Mami
Obara, Taku
- License Information
-
More Information
Article History
Received: 18 January 2022
Revised: 11 May 2022
Accepted: 27 May 2022
First Online: 20 June 2022
Compliance with ethical standards
:
: HM concurrently holds the noncompensated subdirectorship at the Tohoku Institute for Management of Blood Pressure, which is supported by Omron Health Care Co. Ltd., and is involved in collaborative research with Omron Health Care in another study. HM has also received grants or scholarships from Academic Contributions from Pfizer Japan Inc., Astellas Research Support, Daiichi Sankyo Co. Ltd., Bayer Academic Support, Otsuka Pharmaceutical Co., Ltd, Takeda Research Support, Eli Lilly Japan K.K., Baxter Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical Co., Ltd., and Teijin Pharma Limited. These companies were not involved in this review article.
Free to read: This content has been made available to all.
